BLRX
Price
$0.10
Change
-$0.02 (-16.67%)
Updated
Jan 17 closing price
Capitalization
20.43M
67 days until earnings call
TGTX
Price
$29.55
Change
+$0.41 (+1.41%)
Updated
Jan 17 closing price
Capitalization
4.6B
45 days until earnings call
Ad is loading...

BLRX vs TGTX

Header iconBLRX vs TGTX Comparison
Open Charts BLRX vs TGTXBanner chart's image
BioLineRx
Price$0.10
Change-$0.02 (-16.67%)
Volume$25.88M
Capitalization20.43M
TG Therapeutics
Price$29.55
Change+$0.41 (+1.41%)
Volume$2.13M
Capitalization4.6B
BLRX vs TGTX Comparison Chart
Loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLRX vs. TGTX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRX is a Hold and TGTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (BLRX: $0.10 vs. TGTX: $29.55)
Brand notoriety: BLRX and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLRX: 270% vs. TGTX: 77%
Market capitalization -- BLRX: $20.43M vs. TGTX: $4.6B
BLRX [@Biotechnology] is valued at $20.43M. TGTX’s [@Biotechnology] market capitalization is $4.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLRX’s FA Score shows that 1 FA rating(s) are green whileTGTX’s FA Score has 0 green FA rating(s).

  • BLRX’s FA Score: 1 green, 4 red.
  • TGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TGTX is a better buy in the long-term than BLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLRX’s TA Score shows that 4 TA indicator(s) are bullish while TGTX’s TA Score has 3 bullish TA indicator(s).

  • BLRX’s TA Score: 4 bullish, 4 bearish.
  • TGTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BLRX is a better buy in the short-term than TGTX.

Price Growth

BLRX (@Biotechnology) experienced а -28.97% price change this week, while TGTX (@Biotechnology) price change was +2.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

BLRX is expected to report earnings on May 21, 2025.

TGTX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($4.6B) has a higher market cap than BLRX($20.4M). TGTX YTD gains are higher at: -1.827 vs. BLRX (-52.570). TGTX has higher annual earnings (EBITDA): 5.82M vs. BLRX (-13.32M). TGTX has more cash in the bank: 341M vs. BLRX (29.2M). BLRX has less debt than TGTX: BLRX (29.6M) vs TGTX (254M). TGTX has higher revenues than BLRX: TGTX (265M) vs BLRX (22M).
BLRXTGTXBLRX / TGTX
Capitalization20.4M4.6B0%
EBITDA-13.32M5.82M-229%
Gain YTD-52.570-1.8272,877%
P/E RatioN/A39.56-
Revenue22M265M8%
Total Cash29.2M341M9%
Total Debt29.6M254M12%
FUNDAMENTALS RATINGS
BLRX vs TGTX: Fundamental Ratings
BLRX
TGTX
OUTLOOK RATING
1..100
8415
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
84
Overvalued
PROFIT vs RISK RATING
1..100
10061
SMR RATING
1..100
9992
PRICE GROWTH RATING
1..100
9840
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BLRX's Valuation (27) in the Pharmaceuticals Other industry is somewhat better than the same rating for TGTX (84) in the Biotechnology industry. This means that BLRX’s stock grew somewhat faster than TGTX’s over the last 12 months.

TGTX's Profit vs Risk Rating (61) in the Biotechnology industry is somewhat better than the same rating for BLRX (100) in the Pharmaceuticals Other industry. This means that TGTX’s stock grew somewhat faster than BLRX’s over the last 12 months.

TGTX's SMR Rating (92) in the Biotechnology industry is in the same range as BLRX (99) in the Pharmaceuticals Other industry. This means that TGTX’s stock grew similarly to BLRX’s over the last 12 months.

TGTX's Price Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for BLRX (98) in the Pharmaceuticals Other industry. This means that TGTX’s stock grew somewhat faster than BLRX’s over the last 12 months.

TGTX's P/E Growth Rating (99) in the Biotechnology industry is in the same range as BLRX (100) in the Pharmaceuticals Other industry. This means that TGTX’s stock grew similarly to BLRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLRXTGTX
RSI
ODDS (%)
Bullish Trend 5 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
84%
Momentum
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
84%
MACD
ODDS (%)
Bearish Trend 5 days ago
84%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
82%
Advances
ODDS (%)
Bullish Trend 16 days ago
80%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 13 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
78%
View a ticker or compare two or three
Ad is loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

BLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLRX has been loosely correlated with AEON. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BLRX jumps, then AEON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLRX
1D Price
Change %
BLRX100%
-16.74%
AEON - BLRX
33%
Loosely correlated
-9.89%
INSM - BLRX
30%
Poorly correlated
-0.33%
KURA - BLRX
29%
Poorly correlated
+1.11%
TGTX - BLRX
28%
Poorly correlated
+1.41%
PYXS - BLRX
28%
Poorly correlated
+2.04%
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with EDIT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
+1.41%
EDIT - TGTX
39%
Loosely correlated
-1.61%
VANI - TGTX
38%
Loosely correlated
-0.83%
CRNX - TGTX
37%
Loosely correlated
+2.38%
CLLS - TGTX
36%
Loosely correlated
-1.99%
ALT - TGTX
36%
Loosely correlated
+2.24%
More